Skip to main content
. 2016 Mar 1;7(14):18927–18939. doi: 10.18632/oncotarget.7816

Figure 3. SIRT2 inhibits Skp2 in NSCLC cells.

Figure 3

SIRT2 levels were modified in A549 cells by transfection the cells with either SIRT2, or shSIRT2 or a scrambled sequence as a control (scr). A. RT-qPCR for SIRT2 mRNA in SIRT2-modified A549 cells. B. Representative Western blots for SIRT2, Sep2 and p27 in SIRT2-modified A549 cells. C–E. Quantification for SIRT2 (C), Sep2 (D) and p27 (E) protein in SIRT2-modified A549 cells. *p<0.05. N=5.